DynaMesh®-PRS
DynaMesh®-PRS soft and DynaMesh®-PRS visible implants are intended to be used as bridging material and reinforce the soft tissue of the vaginal walls as part of surgical treatment for apical pelvic organ prolapse.
DynaMesh®-PRSProduct RangeUse and PropertiesVideosFurther Product Information
Application Examples:
Colpo-/cervicosacropexy
- unilateral
Colpo-/cervicosacropexy
- unilateral
- anterior/posterior mesh plasty (for concomitant cystocele/rectocele)
Colpo-/cervicosacropexy
- unilateral
| DynaMesh®-PRS soft |
02 cm x 16 cm | PV350216F1 |
| DynaMesh®-PRS soft | 03 cm x 23 cm | PV350323F1 |
| DynaMesh®-PRS visible |
03 cm x 23 cm | PV750323F1/F10 |
| DynaMesh®-PRS visible | 3.3 cm x 24 cm | PV750424F1/F10 |
| DynaMesh®-PRS visible | 04 cm x 20 cm | PV750420F1/F10 |
| DynaMesh®-PRS soft |
05 cm x 27 cm | PV350527F1 |
| FX = X unit(s)/box (e.g. F3 = 3 unit(s)/box) |
| Product | DynaMesh®-PRS soft (1) DynaMesh®-PRS visible (2) |
| Surgical Treatment | Apical Pelvic Organ Prolapse (Vaginal Stump / Cervical Stump) |
| Surgical Approach | Minimally Invasive / Open |
| Surgical Technique | Sacropexy |
| Fixation | – Anterior longitudinal ligament: non-absorbable suture or tacks – Vaginal/cervical stump and vaginal walls: interrupted non-absorbable suture |
| Smooth Warp-Knitted Selvedges |  |
| Defined Elasticity |
[TR130] |
| Visible Technology |  (1) /  (2) |
| Materials |
– Polyvinylidene fluoride (PVDF) (CAS 24937-79-9) > 99% (w/w) (1) (2)
– Triiron tetraoxide (CAS 1317-61-9) < 1% (w/w) (2) |
| Polymer (Monofilament) |
PVDF
|
| Biocompatibility | [TR1] |
| Ageing Resistance | [2A, 5VIT, 27A, 52VIT, 93A, 101] |
| Effective Porosity | High effective porosity reduces inflammation and the risk of excessive scar formation. [103P, TR132] |
| Klinge’s Mesh Classification | Class 1a [102P, TR132] |
|
Applies to all product sizes |
|
Does not apply |
| [#] | Reference “#” (see “References”) |
| [TR#] | Internal test report (see “internal test report references”) |
| Limitations | “A” animal trial, “B” bench test, “VIT” in-vitro trial, “P” published results based on the analysis of human mesh explants, “PB” published results mainly based on bench tests |
